No Data
No Data
Virax Biolabs Debuts ImmuneSelect Portfolio
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersProcessa Pharma (NASDAQ:PCSA) shares moved upwards by 31.2% to $2.12 during Thursday's pre-market session. The company's market cap stands at $6.0 million. Cyclacel Pharmaceuticals (NASDAQ:CYCC
Express News | EXCLUSIVE: Virax Biolabs Tells Benzinga 'The Launch Marks a Significant Milestone for Virax as It Brings Us a Step Closer to Commercializing ViraxImmuneTM as a Full In-Vitro-Diagnostic Product'
Express News | EXCLUSIVE: Virax Biolabs Tells Benzinga Co. Launches Portfolio Of Immune Profiling Solutions Evaluating Adaptive Immunity In Post-Viral Syndromes
EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In Post-Viral Syndromes
Thursday, Virax Biolabs Group Limited (NASDAQ: VRAX) announced it is launching 'ImmuneSelect' within the ViraxImmune T-Cell diagnostic platform for research-use-only (RUO) at the European Society of C
Virax Biolabs Showcases Innovations at ESCMID 2024
No Data